Research news

Vision restoration by molecular prostheses

magen histológica de la retina de un animal rd10 al mes de edad, en la que se observa una alteración importante de la capa de los fotorreceptores de la retina.

Imagen histológica de la retina de un animal rd10 al mes de edad, en la que se observa una alteración importante de la capa de los fotorreceptores de la retina. A new route towards treatment to recover sight based on controlling the activity of small molecules

The groups of Pau Gorostiza, ICREA Research Professor at IBEC, and Amadeu Llebaria of IQAC-CSIC have developed molecules that can be applied as light-regulated molecular prostheses to help restore vision in cases of retinal degeneration.

Together with their collaborators at ICIQ, INA, IRB Barcelona, CIBER-BBN and the Miguel Hernández and Alcalá de Henares universities, the researchers reveal in Nature Communications today their development of a new class of light-regulated drug, targeted covalent photoswitches (TCPs), that act as prosthetic molecules that can restore photoresponses in degenerated retinas.

Read more…

Other news

IBEC a key member of the new RIS3CAT communities

ris3cat

ris3catIBEC is a member of one of five ‘communities’ that will receive funding as part of the RIS3CAT intiative, which aims to enable and promote large projects in Catalonia that combine industry and research.

In the launch meeting at the headquarters of RIS3CAT coordinator ACCIO – the government’s agency for competitivity in business – on Monday, Minister for Business and Enterprise Jordi Baiget, who chaired the event alongside Director General of Industry Nuria Betriu, declared RIS3CAT “the greatest ever effort for innovation in Catalonia”.

IBEC is a member of NEXTHEALTH, one of two health-related RIS3CAT communities among the five, all of which bring together businesses, research organizations, hospitals, and other major players to form a critical mass to work in collaboration on large-scale projects to boost innovation.

Read more…